BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32588132)

  • 21. NUT midline carcinoma of the larynx: an international series and review of the literature.
    Hellquist H; French CA; Bishop JA; Coca-Pelaz A; Propst EJ; Paiva Correia A; Ngan BY; Grant R; Cipriani NA; Vokes D; Henrique R; Pardal F; Vizcaino JR; Rinaldo A; Ferlito A
    Histopathology; 2017 May; 70(6):861-868. PubMed ID: 27926786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUT midline carcinomas in the thymic region.
    Gökmen-Polar Y; Cano OD; Kesler KA; Loehrer PJ; Badve S
    Mod Pathol; 2014 Dec; 27(12):1649-56. PubMed ID: 24851833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
    Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
    J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NUT Midline Carcinoma of the Lung in a Six-Year-Old Child.
    Karakuş E; Poyraz A; Oğuz Erdogan AS; Emir S; Özyörük D
    Fetal Pediatr Pathol; 2017 Dec; 36(6):472-474. PubMed ID: 29220605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncommon somatic mutations in metastatic NUT midline carcinoma.
    Cavalieri S; Stathis A; Fabbri A; Sonzogni A; Perrone F; Tamborini E; Pelosi G; de Braud F; Platania M
    Tumori; 2017 Nov; 103(Suppl. 1):e5-e8. PubMed ID: 28967088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytological features of NUT midline carcinoma arising in sino-nasal tract and parotid gland: Report of two new cases and review of the literature.
    Klijanienko J; Le Tourneau C; Rodriguez J; Caly M; Theocharis S
    Diagn Cytopathol; 2016 Sep; 44(9):753-6. PubMed ID: 27338676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NUT Carcinoma of the Submandibular Gland: A Case at This Uncommon Site with Review of the Literature.
    Moreno V; French CA; Guo T; Zhu H; Zhang S; Duncan D; Karni RJ; Blanco AI; Jafri SH; Saluja K
    Head Neck Pathol; 2022 Sep; 16(3):881-892. PubMed ID: 34905155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Overview of Molecular Mechanism, Clinicopathological Factors, and Treatment in NUT Carcinoma.
    Huang QW; He LJ; Zheng S; Liu T; Peng BN
    Biomed Res Int; 2019; 2019():1018439. PubMed ID: 31815119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary pulmonary NUT midline carcinoma: An elusive and a rare diagnostic entity.
    Pasricha S; Jajodia A; Sharma A; Bansal D; Batra U; Gupta G; Durga G; Kamboj M; Nathany S; Mehta A
    J Cancer Res Ther; 2023; 19(3):816-818. PubMed ID: 37470617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging entities in NUTM1-rearranged neoplasms.
    McEvoy CR; Fox SB; Prall OWJ
    Genes Chromosomes Cancer; 2020 Jun; 59(6):375-385. PubMed ID: 32060986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demystified molecular pathology of NUT midline carcinomas.
    French CA
    J Clin Pathol; 2010 Jun; 63(6):492-6. PubMed ID: 18552174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
    Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
    Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases.
    Giridhar P; Mallick S; Kashyap L; Rath GK
    Eur Arch Otorhinolaryngol; 2018 Mar; 275(3):815-821. PubMed ID: 29356890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
    Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
    Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Mutation Burden and Checkpoint Immunotherapy Markers in NUT Midline Carcinoma.
    He M; Chernock R; Zhou S; Gondim M; Dehner LP; Pfeifer JD
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):495-500. PubMed ID: 31180909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A Case Report of Primary Pulmonary NUT Carcinoma and Literature Review].
    Liu X; Li Y; Yu M; Zhou L
    Zhongguo Fei Ai Za Zhi; 2021 Jan; 24(1):63-68. PubMed ID: 33478193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges and Opportunities in NUT Carcinoma Research.
    Hakun MC; Gu B
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear protein in testis midline carcinoma of larynx: An underdiagnosed entity.
    Kundra A; Andrei M; Westra W; Chaudhry R; Moussouris H; Gohari A; Wang JC
    Head Neck; 2016 Aug; 38(8):E2471-4. PubMed ID: 27028217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NUT carcinoma of the thorax: Case report and review of the literature.
    Harms A; Herpel E; Pfarr N; Penzel R; Heussel CP; Herth FJ; Dienemann H; Weichert W; Warth A
    Lung Cancer; 2015 Dec; 90(3):484-91. PubMed ID: 26490121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.
    Suzuki S; Kurabe N; Ohnishi I; Yasuda K; Aoshima Y; Naito M; Tanioka F; Sugimura H
    Pathol Res Pract; 2015 May; 211(5):404-8. PubMed ID: 25466466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.